Diabetes mellitus, a metabolic disease characterized by hyperglycemia and poor glucose control, is a risk factor for () infection and the development of active tuberculosis. To evaluate whether infection susceptibility is associated with an intrinsic factor in monocytes from type 2 diabetes (T2D) patients or it is associated with hyperglycemia , we analyzed TLR-2 and TLR-4 expression by flow cytometry and the cytokines IL-1, IL-6, IL-8, IL-10, and TNF- by cytometric bead array assays, either stimulated with TLR-2 and TLR-4 ligands or infected with in the whole blood from T2D patients ( = 43) and healthy subjects ( = 26) or in CD14+ monocytes from healthy subjects cultured in high glucose (HG) (30 mM). The intracellular growth of was evaluated by CFU counts at 0, 1, and 3 days in both monocytes from T2D patients and monocytes from healthy subjects cultured in HG. We did not find significant differences in TLR expression, cytokine production, or growth of in monocytes from T2D patients compared with those in monocytes from healthy subjects. Despite these results, assays of monocytes cultured with 30 mM glucose led to significantly increased TLR-2 and TLR-4 basal expression compared to those of monocytes cultured with 11 mM glucose ( < 0.05). Conversely, the production of IL-6 by TLR-2 ligand stimulation, of IL-1, IL-6, and IL-8 by TLR-4 ligand stimulation, and of IL-8 by infection significantly decreased in monocytes cultured in HG ( < 0.05). Additionally, the intracellular survival of increased in monocytes in HG after day 3 of culture ( < 0.05). In conclusion, HG decreased IL-8 production and the intracellular growth control of by monocytes, supporting the hypothesis that hyperglycemia plays an important role in the impaired immune responses to in patients with T2D.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877949 | PMC |
http://dx.doi.org/10.1155/2019/1462098 | DOI Listing |
Endocrinol Metab (Seoul)
January 2025
Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Background: Achieving optimal glucose control is essential in the management of type 2 diabetes (T2D). This study aimed to evaluate the effectiveness and safety of oral quadruple combination therapy for the treatment of T2D.
Methods: This meta-analysis reviewed original research on oral quadruple combination therapy for T2D, including both experimental and observational studies with a minimum duration of 12 weeks.
Euroasian J Hepatogastroenterol
December 2024
Department of Endocrinology, Medicell Institute of Diabetes Endocrinology and Metabolism (MIDEM), Karachi, Sindh, Pakistan.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is an important entity in patients with type-2 diabetes (T2D). Exploring the prevalence and related factors of MASLD is vital toward developing effective methods of diagnosis and treatment. The objective of this study was to determine the prevalence of MASLD in persons with obesity and T2D.
View Article and Find Full Text PDFDiabetes Metab Syndr Obes
January 2025
School of Marxism, Capital Normal University, Beijing, People's Republic of China.
With the aging of China's population and lifestyle changes, the number of patients with type 2 diabetes (T2D) has surged, posing a significant challenge to the public health system. This study explores the application and effectiveness of artificial intelligence (AI) technology in T2D management from a Chinese perspective. AI demonstrates substantial potential in personalized treatment planning, real-time monitoring and early warning, telemedicine, and health management.
View Article and Find Full Text PDFCirc Cardiovasc Imaging
January 2025
Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (Y. Lin, M.X., L.Z., Y.Z., P.Z., X.C., M.J., L.G., Q.H., Z.W., Y.Y., Y. Li).
Background: In patients with heart failure with preserved ejection fraction (HFpEF), the impact of type 2 diabetes (T2D) on left ventricular global longitudinal strain (LV GLS) and its prognostic implications remains unclear. We aimed to evaluate LV function using two-dimensional (2D) and three-dimensional (3D) speckle-tracking echocardiography in patients with HFpEF with and without T2D, and to investigate its prognostic significance.
Methods: A total of 335 patients with HFpEF were prospectively enrolled for echocardiographic evaluation.
Introduction: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated neuroprotective effects and hold potential advantages in enhancing cognitive function. This study aims to clarify the association between SGLT2 inhibitors and the risk of dementia among individuals diagnosed with type 2 diabetes (T2D).
Methods: All cohort studies concerning the impact of SGLT2 inhibitors on dementia onset in patients with T2D were identified.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!